Revolutionary Cancer Vaccines: Moderna and Mark's Game-Changing Breakthrough

The aim is to reach 10,000 patients by 2030 common Moderna and Mark are the big names here They're developing experimental cancer vaccines and their target is melanoma The most deadly skin cancer The development is at a mid stage And so far the vaccines have cut the chance of recurrence or death by half after three years of treatment